Literature DB >> 9451615

Low energy availability, not stress of exercise, alters LH pulsatility in exercising women.

A B Loucks1, M Verdun, E M Heath.   

Abstract

We tested two hypotheses about the disruption of luteinizing hormone (LH) pulsatility in exercising women by assaying LH in blood samples drawn at 10-min intervals over 24 h from nine young, habitually sedentary, regularly menstruating women on days 8, 9, or 10 of two menstrual cycles after 4 days of intense exercise [E = 30 kcal.kg lean body mass (LBM)-1.day-1 at 70% of aerobic capacity]. To test the hypothesis that LH pulsatility is disrupted by low energy availability, we controlled the subjects' dietary energy intakes (I) to set their energy availabilities (A = I - E) at 45 and 10 kcal.kg LBM-1.day-1 during the two trials. To test the hypothesis that LH pulsatility is disrupted by the stress of exercise, we compared the resulting LH pulsatilities to those previously reported in women with similar controlled energy availability who had not exercised. In the exercising women, low energy availability reduced LH pulse frequency by 10% (P < 0.01) during the waking hours and increased LH pulse amplitude by 36% (P = 0.05) during waking and sleeping hours, but this reduction in LH pulse frequency was blunted by 60% (P = 0.03) compared with that in the previously studied nonexercising women whose low energy availability was caused by dietary restriction. The stress of exercise neither reduced LH pulse frequency nor increased LH pulse amplitude (all P > 0.4). During exercise, the proportion of energy derived from carbohydrate oxidation was reduced from 73% while A = 45 kcal.kg LBM-1.day-1 to 49% while A = 10 kcal.kg LBM-1.day-1 (P < 0.0001). These results contradict the hypothesis that LH pulsatility is disrupted by exercise stress and suggest that LH pulsatility in women depends on energy availability.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9451615     DOI: 10.1152/jappl.1998.84.1.37

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  90 in total

Review 1.  Estrogen replacement therapy and female athletes: current issues.

Authors:  D C Cumming; C E Cumming
Journal:  Sports Med       Date:  2001       Impact factor: 11.136

Review 2.  Who owns the information? Databases of injuries in professional sport are valuable resources which should not suffer confidentiality restraints.

Authors:  J Orchard
Journal:  Br J Sports Med       Date:  2002-02       Impact factor: 13.800

3.  New criteria for female athlete triad syndrome? As osteoporosis is rare, should osteopenia be among the criteria for defining the female athlete triad syndrome?

Authors:  K M Khan; T Liu-Ambrose; M M Sran; M C Ashe; M G Donaldson; J D Wark
Journal:  Br J Sports Med       Date:  2002-02       Impact factor: 13.800

4.  Banning pregnant netballers--is this the answer?

Authors:  S White
Journal:  Br J Sports Med       Date:  2002-02       Impact factor: 13.800

5.  Physiological factors associated with low bone mineral density in female endurance runners.

Authors:  M Burrows; A M Nevill; S Bird; D Simpson
Journal:  Br J Sports Med       Date:  2003-02       Impact factor: 13.800

Review 6.  Effects of estrogen replacement on metabolic factors that influence physical performance in female hypogonadism.

Authors:  W M Kohrt; R E Van Pelt; W S Gozansky
Journal:  J Endocrinol Invest       Date:  2003-09       Impact factor: 4.256

Review 7.  The neuroendocrine basis of lactation-induced suppression of GnRH: role of kisspeptin and leptin.

Authors:  M Susan Smith; Cadence True; K L Grove
Journal:  Brain Res       Date:  2010-08-19       Impact factor: 3.252

Review 8.  Low Energy Availability in Exercising Women: Historical Perspectives and Future Directions.

Authors:  Joanne Slater; Rachel Brown; Rebecca McLay-Cooke; Katherine Black
Journal:  Sports Med       Date:  2017-02       Impact factor: 11.136

Review 9.  Female athlete triad.

Authors:  Karen Birch
Journal:  BMJ       Date:  2005-01-29

Review 10.  Oligomenorrhoea in exercising women: a polycystic ovarian syndrome phenotype or distinct entity?

Authors:  Susan Awdishu; Nancy I Williams; Sheila E Laredo; Mary Jane De Souza
Journal:  Sports Med       Date:  2009       Impact factor: 11.136

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.